Characteristics of patients who did not receive a transplant (n = 158) compared with transplant recipients (n = 96)
. | Patients . | . | . | |
|---|---|---|---|---|
| Characteristic . | No transplant . | Transplant recipients . | P . | |
| Age, y (range) | 43 (24.5-71.5) | 19.4 (3.3-53.3) | < .0001 | |
| Male sex, no. (%) | 84 (53) | 53 (56) | Not significant | |
| Source of infection | ||||
| Transfusion, no. (%) | 68 (43) | Not applicable | Not applicable | |
| Intravenous drug user, no. (%) | 90 (57) | Not applicable | Not applicable | |
| Genotype* (1/2/3/4) | 74/4/38/15 | 35/14/12/4 | .001 | |
| Duration of HCV infection, y (range) | 20.6 (5-51) | 15.7 (13-19.5) | < .0001 | |
| Alcohol greater than 20 g/d, no. (%) | 36 (23) | 7 (7) | .001 | |
| Steatosis, no. (%) | 67 (42) | 23 (34) | NS | |
| Hemosiderosis, no. (%) | 22 (14) | 24 (36) | .0004 | |
. | Patients . | . | . | |
|---|---|---|---|---|
| Characteristic . | No transplant . | Transplant recipients . | P . | |
| Age, y (range) | 43 (24.5-71.5) | 19.4 (3.3-53.3) | < .0001 | |
| Male sex, no. (%) | 84 (53) | 53 (56) | Not significant | |
| Source of infection | ||||
| Transfusion, no. (%) | 68 (43) | Not applicable | Not applicable | |
| Intravenous drug user, no. (%) | 90 (57) | Not applicable | Not applicable | |
| Genotype* (1/2/3/4) | 74/4/38/15 | 35/14/12/4 | .001 | |
| Duration of HCV infection, y (range) | 20.6 (5-51) | 15.7 (13-19.5) | < .0001 | |
| Alcohol greater than 20 g/d, no. (%) | 36 (23) | 7 (7) | .001 | |
| Steatosis, no. (%) | 67 (42) | 23 (34) | NS | |
| Hemosiderosis, no. (%) | 22 (14) | 24 (36) | .0004 | |
Genotype was unknown in 27 transplant recipients, and genotype 2 is also more frequent in the transplant recipient group.